Lee’s Pharmaceutical (SEHK: 0950, www.leespharm.com) is an integrated research-driven and market-oriented biopharmaceutical company publicly listed in Hong Kong with over 25 years’ experience in the pharmaceutical industry in China. The Group focuses on several key disease areas such as cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology and obstetrics etc. Lee’s Pharmaceutical is fully integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales and marketing based in Mainland China with global perspectives.
Lee’s Pharmaceutical (SEHK: 0950, www.leespharm.com) is an integrated research-driven and market-oriented biopharmaceutical company publicly listed in Hong Kong with over 25 years’ experience in the pharmaceutical industry in China. The Group focuses on several key disease areas such as cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology and obstetrics etc. Lee’s Pharmaceutical is fully integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales and marketing based in Mainland China with global perspectives.